Literature DB >> 11400198

Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts.

P Mauri1, P Simonetti, C Gardana, M Minoggio, P Morazzoni, E Bombardelli, P Pietta.   

Abstract

Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry (LC/APCI-ITMS) was applied to evaluate the levels of ginkgolides A and B and bilobalide in plasma of volunteers after administration of Ginkgo biloba extracts in free (Ginkgoselect) or phospholipid complex (Ginkgoselect Phytosome) forms, providing 9.6 mg of total terpene lactones. The maximum plasma concentrations, C(max), of total ginkgolides A, B and bilobalide were 85.0 and 181.8 microg/mL for Ginkgoselect and Ginkgoselect Phytosome, respectively. The C(max) values were reached at 120 min for the free form and at 180--240 min for the phospholipid complex form. In both cases, the mean elimination half-life of each terpene lactone was in the range 120--180 min. Due to its sensitivity (about 1 ng/mL) and specificity, LC/APCI-ITMS proved to be a very powerful tool for pharmacokinetic studies of these phytochemicals. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11400198     DOI: 10.1002/rcm.316

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  13 in total

1.  Liquid chromatography/electrospray tandem mass spectrometry of terpenoid lactones in Ginkgo biloba.

Authors:  Yongkai Sun; Wenkui Li; John F Fitzloff; Richard B van Breemen
Journal:  J Mass Spectrom       Date:  2005-03       Impact factor: 1.982

2.  The gallic acid-phospholipid complex improved the antioxidant potential of gallic acid by enhancing its bioavailability.

Authors:  Sauvik Bhattacharyya; Sk Milan Ahammed; Bishnu Pada Saha; Pulok K Mukherjee
Journal:  AAPS PharmSciTech       Date:  2013-06-26       Impact factor: 3.246

3.  The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers.

Authors:  Andrew K L Goey; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Eur J Clin Pharmacol       Date:  2013-07-24       Impact factor: 2.953

4.  Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity.

Authors:  Xin-Wei Liu; Jun-Ling Yang; Wei Niu; Wei-Wei Jia; Olajide E Olaleye; Qi Wen; Xiao-Na Duan; Yü-Hong Huang; Feng-Qing Wang; Fei-Fei Du; Chen-Chun Zhong; Yan-Fen Li; Fang Xu; Qi Gao; Li Li; Chuan Li
Journal:  Acta Pharmacol Sin       Date:  2018-07-27       Impact factor: 6.150

5.  Simultaneous determination of ginkgo flavonoids and terpenoids in plasma: ammonium formate in LC mobile phase enhancing electrospray ionization efficiency and capacity.

Authors:  Yang Zhao; Yan Sun; Chuan Li
Journal:  J Am Soc Mass Spectrom       Date:  2007-11-29       Impact factor: 3.109

Review 6.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

7.  Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021.

Authors:  Shi-Hai Xia; Chun-Xiu Hu; Zhi-Ling Zhao; Guo-Dong Xia; Yao Di
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

8.  Roles of BN52021 in platelet-activating factor pathway in inflammatory MS1 cells.

Authors:  Shi-Hai Xia; Xiao-Hui Xiang; Kai Chen; Wei Xu
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

9.  Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways.

Authors:  Jia-Shiong Chen; Yung-Hsiang Chen; Po-Hsun Huang; Hsiao-Ya Tsai; Yuh-Lien Chen; Shing-Jong Lin; Jaw-Wen Chen
Journal:  Cardiovasc Diabetol       Date:  2012-05-03       Impact factor: 9.951

10.  TRIM25 Rescues Against Doxorubicin-Induced Pyroptosis Through Promoting NLRP1 Ubiquitination.

Authors:  Xiaxia Wang; Zhexun Lian; Yiping Ge; Dongqiang Yu; Shan Li; Kai Tan
Journal:  Cardiovasc Toxicol       Date:  2021-07-27       Impact factor: 3.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.